NF-κB2 is required for optimal CD40-induced IL-12 production but dispensable for Th1 cell differentiation

Journal of Immunology

Volumn 168, Issue 9, 2002, Pages 4406-4413

  Speirs, Kendra ^a   Caamano, Jorge ^a   Goldschmidt, Michael H ^a   Hunter, Christopher A ^a   Scott, Phillip ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; RAG1 PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; IMMUNOREGULATION; LEISHMANIA MAJOR; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN LEISHMANIASIS; TH1 CELL;

EID: 0036569015     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.9.4406     Document Type: Article

References (59)

1. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses
2. Regulation of RANTES chemokine gene expression requires cooperativity between NF-κB and IFN-regulatory factor transcription factors
3. The NF-κB and IκB proteins: New discoveries and insights
4. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB
5. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses
6. Multifocal defects in immune responses in RelB-deficient mice
7. Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions
8. Mice deficient in nuclear factor NF-κB/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture
9. The NF-κB family member RelB is required for innate and adaptive immunity to Toxoplasma gondii
10. Identification of a role for NF-κB2 in the regulation of apoptosis and in maintenance of T cell-mediated immunity to Toxoplasma gondii
11. Genetic approaches to study Rel/NF-κB/IκB function in mice
12. Functional diversity of helper T lymphocytes
13. Induction of interleukin-12 p40 transcript by CD40 ligation via activation of nuclear factor-κB
14. Interaction of NF-κB and NFAT with the interferon-γ promoter
15. Constitutive and inducible Rel/NF-κB activities in mouse thymus and spleen
16. IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-κB is decisively involved in the expression of IL-9
17. Preferential role for NF-κB/Rel signaling in the type 1 but not type 2 T cell-dependent immune response in vivo
18. A critical role for NF-κB in GATA3 expression and TH2 differentiation in allergic airway inflammation
19. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-KB p50
20. Nuclear factor NF-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses
21. + T cell subsets in experimental cutaneous leishmaniasis
22. Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis: Evidence for expansion of distinct helper T cell subsets
23. Recombinant interleukin 12 cures mice infected with Leishmania major
24. Resolution of cutaneous leishmaniasis: Interleukin 12 initiates a protective T helper type 1 immune response
25. Identification of an infective stage of Leishmania promastigotes
26. Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy
27. Bone marrow-derived macrophages: Development and regulation of differentiation markers by colony-stimulating factor and interferons
28. Intracellular replication of Leishmania tropica in mouse peritoneal macrophages: Comparison of amastigote replication in adherent and nonadherent macrophages
29. 15N]nitrate in biological fluids
30. Vaccination against cutaneous leishmaniasis in a murine model. II. Immunologic properties of protective and nonprotective subfractions of soluble promastigote extract
31. Specific assays for cytokine production by T cells
32. Determination of lymphocyte division by flow cytometry
33. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper I and T helper 2 populations
34. Role of transcription factor NF-κ/Rel in induction of nitric oxide synthase
35. fyn tyrosine kinases in human lymphocytes
36. Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: Evidence of functional synergy between C/EBP and Rel proteins
37. Selective requirement for c-Rel during IL-12 p40 gene induction in macrophages
38. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response
39. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity
40. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection
41. CD40 ligand is required for protective cell-mediated immunity to Leishmania major
42. Lineage-restricted function of nuclear factor κB-inducing kinase (NIK) in transducing signals via CD40
43. NF-κB-inducing kinase regulates the processing of NF-κB2 p100
44. Regulation of immune responses by NF-κB/Rel transcription factor
45. c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function
46. Developmental expression of the mouse c-rel proto-oncogene in hematopoietic organs
47. Differential nuclear localization of p50, p52, and RelB proteins in human accessory cells of the immune response in situ
48. The Rel subunit of NF-κB-like transcription factors is a positive and negative regulator of macrophage gene expression: Distinct roles for Rel in different macrophage populations
49. The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb
50. Molecular mechanisms of CD40 signaling
51. Requirement for NF-κB activation by a distinct subset of CD40-mediated effector functions in B lymphocytes
52. Specificities of CD40 signaling: Involvement of TRAF2 in CD40-induced NF-κB activation and intercellular adhesion molecule-1 up-regulation
53. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: Regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization
54. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia
55. The CD40/CD40 ligand interaction is required for resistance to toxoplasmic encephalitis
56. Regulation of nuclear factor κB activation by G-protein-coupled receptors
57. Tumor necrosis factor α-induced E-selectin expression is activated by the nuclear factor-κB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways
58. CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin
59. NF-κB activation is required for interferon regulatory factor-1-mediated interferon β induction